AstraZeneca PLC
(BSP:A1ZN34)
R$
70.56
-0.98 (-1.37%)
Market Cap: 656.32 Bil
Enterprise Value: 800.61 Bil
PE Ratio: 38.20
PB Ratio: 6.49
GF Score: 84/100 AstraZeneca PLC Investor Science Conference Call: Farxiga's DAPA-HF trial at ESC Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot